Table 1.
Characteristics of study participants with three antiphospholipid antibodies in the GWAS dataset*.
| ACL | LAC | Anti-β 2GPI | ||||
|---|---|---|---|---|---|---|
| Positive | Negative | Positive | Negative | Positive | Negative | |
| (n = 183) | (n = 487) | (n = 127) | (n = 581) | (n = 136) | (n = 360) | |
| Mean age ± SD | 46.92 ± 11.41 | 46.19 ± 10.85 | 45.64 ± 11.35 | 46.40 ± 11.36 | 45.91 ± 10.68 | 46.79 ± 11.18 |
| SLE cases (%) | 58.5 | 58.1 | 70.8 | 56.3 | 71.3 | 51.9 |
| Controls (%) | 41.5 | 41.9 | 29.2 | 43.7 | 28.7 | 48.1 |
*ACL: anticardiolipin antibodies; LAC: lupus anticoagulant; Anti-β 2GPI: anti-β 2 glycoprotein I antibodies.